Clearbridge Investments, LLC Bristol Myers Squibb CO Transaction History

Clearbridge Investments, LLC

  • $119 Billion
  • Q2 2024

A detailed history of Clearbridge Investments, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Clearbridge Investments, LLC holds 106,270 shares of BMY stock, worth $5.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
106,270
Previous 106,270 -0.0%
Holding current value
$5.65 Million
Previous $4.41 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$40.25 - $52.99 $720,877 - $949,050
-17,910 Reduced 14.42%
106,270 $4.41 Million
Q1 2024

May 13, 2024
SELL
$47.98 - $54.4 $86,364 - $97,920
-1,800 Reduced 1.43%
124,180 $6.73 Million
Q4 2023

Feb 09, 2024
BUY
$48.48 - $57.85 $656,128 - $782,941
13,534 Added 12.04%
125,980 $6.46 Million
Q3 2023

Nov 13, 2023
BUY
$57.89 - $64.73 $26,571 - $29,711
459 Added 0.41%
112,446 $6.53 Million
Q2 2023

Aug 11, 2023
SELL
$63.71 - $70.74 $305,808 - $339,552
-4,800 Reduced 4.11%
111,987 $7.16 Million
Q1 2023

May 12, 2023
SELL
$65.71 - $74.53 $178,468 - $202,423
-2,716 Reduced 2.27%
116,787 $8.09 Million
Q4 2022

Feb 10, 2023
SELL
$68.48 - $81.09 $132,166 - $156,503
-1,930 Reduced 1.59%
119,503 $8.6 Million
Q3 2022

Nov 14, 2022
SELL
$0.13 - $76.84 $9 - $5,378
-70 Reduced 0.06%
121,433 $8.63 Million
Q2 2022

Aug 11, 2022
SELL
$72.62 - $79.98 $3.05 Million - $3.36 Million
-42,039 Reduced 25.71%
121,503 $9.36 Million
Q1 2022

May 13, 2022
SELL
$61.48 - $73.72 $82,075 - $98,416
-1,335 Reduced 0.81%
163,542 $11.9 Million
Q4 2021

Feb 11, 2022
SELL
$53.63 - $62.52 $158,208 - $184,434
-2,950 Reduced 1.76%
164,877 $10.3 Million
Q3 2021

Nov 12, 2021
BUY
$59.17 - $69.31 $57,394 - $67,230
970 Added 0.58%
167,827 $9.93 Million
Q2 2021

Aug 13, 2021
BUY
$61.91 - $67.42 $224,238 - $244,195
3,622 Added 2.22%
166,857 $11.1 Million
Q1 2021

May 13, 2021
BUY
$59.34 - $66.74 $1.89 Million - $2.12 Million
31,820 Added 24.21%
163,235 $10.3 Million
Q4 2020

Feb 10, 2021
SELL
$57.74 - $65.43 $51.9 Million - $58.8 Million
-898,152 Reduced 87.24%
131,415 $8.15 Million
Q3 2020

Nov 12, 2020
SELL
$57.43 - $63.64 $62.8 Million - $69.5 Million
-1,092,683 Reduced 51.49%
1,029,567 $62.1 Million
Q2 2020

Aug 14, 2020
SELL
$54.82 - $64.09 $6.81 Million - $7.96 Million
-124,219 Reduced 5.53%
2,122,250 $125 Million
Q1 2020

May 15, 2020
SELL
$46.4 - $67.43 $14.6 Million - $21.2 Million
-314,779 Reduced 12.29%
2,246,469 $125 Million
Q4 2019

Feb 14, 2020
BUY
$49.21 - $64.19 $5.34 Million - $6.96 Million
108,460 Added 4.42%
2,561,248 $162 Million
Q3 2019

Nov 14, 2019
BUY
$42.77 - $50.71 $876,998 - $1.04 Million
20,505 Added 0.84%
2,452,788 $124 Million
Q2 2019

Aug 14, 2019
BUY
$44.62 - $49.34 $18 Million - $19.9 Million
402,533 Added 19.83%
2,432,283 $0
Q1 2019

May 15, 2019
SELL
$45.12 - $53.8 $44.3 Million - $52.9 Million
-982,599 Reduced 32.62%
2,029,750 $96.8 Million
Q4 2018

Feb 14, 2019
SELL
$48.76 - $63.23 $2.29 Million - $2.97 Million
-46,913 Reduced 1.53%
3,012,349 $157 Million
Q3 2018

Nov 14, 2018
BUY
$55.19 - $62.25 $19 Million - $21.4 Million
344,278 Added 12.68%
3,059,262 $190 Million
Q2 2018

Aug 14, 2018
SELL
$50.53 - $62.98 $1.08 Million - $1.35 Million
-21,469 Reduced 0.78%
2,714,984 $150 Million
Q1 2018

May 15, 2018
BUY
$59.92 - $68.98 $4.99 Million - $5.74 Million
83,249 Added 3.14%
2,736,453 $173 Million
Q4 2017

Feb 14, 2018
SELL
$59.94 - $65.35 $950,948 - $1.04 Million
-15,865 Reduced 0.59%
2,653,204 $163 Million
Q3 2017

Nov 14, 2017
SELL
$55.23 - $63.74 $225,393 - $260,122
-4,081 Reduced 0.15%
2,669,069 $170 Million
Q2 2017

Aug 14, 2017
BUY
N/A
2,673,150
2,673,150 $149 Million

Others Institutions Holding BMY

# of Institutions
2,428
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Clearbridge Investments, LLC Portfolio

Follow Clearbridge Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email